BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17931358)

  • 1. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
    Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
    Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
    Payne SL; Fogelgren B; Hess AR; Seftor EA; Wiley EL; Fong SF; Csiszar K; Hendrix MJ; Kirschmann DA
    Cancer Res; 2005 Dec; 65(24):11429-36. PubMed ID: 16357151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
    Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
    Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
    Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
    Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
    Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
    J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.
    Payne SL; Hendrix MJ; Kirschmann DA
    J Cell Biochem; 2006 Jul; 98(4):827-37. PubMed ID: 16440329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular role for lysyl oxidase in breast cancer invasion.
    Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
    Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
    Bai XM; Zhang W; Liu NB; Jiang H; Lou KX; Peng T; Ma J; Zhang L; Zhang H; Leng J
    Oncol Rep; 2009 Jan; 21(1):129-36. PubMed ID: 19082453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin promotes invasiveness and focal adhesion kinase tyrosine phosphorylation of human colon cancer cell.
    Ding J; Li D; Wang X; Wang C; Wu T
    Hepatogastroenterology; 2008; 55(88):2072-6. PubMed ID: 19260479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes and molecular expressions of hepatocellular carcinoma cells in three-dimensional culture model.
    Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
    Exp Mol Pathol; 2009 Oct; 87(2):133-40. PubMed ID: 19615356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
    Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
    J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model.
    Bouez C; Reynaud C; Noblesse E; Thépot A; Gleyzal C; Kanitakis J; Perrier E; Damour O; Sommer P
    Clin Cancer Res; 2006 Mar; 12(5):1463-9. PubMed ID: 16533769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal adhesion kinase (FAK) expression and activation during lens development.
    Kokkinos MI; Brown HJ; de Iongh RU
    Mol Vis; 2007 Mar; 13():418-30. PubMed ID: 17417603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paxillin phosphorylation and integrin expression in osteoblasts infected by Porphyromonas gingivalis.
    Elkaim R; Obrecht-Pflumio S; Tenenbaum H
    Arch Oral Biol; 2006 Sep; 51(9):761-8. PubMed ID: 16620778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
    Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
    Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin.
    Huang Z; Yan DP; Ge BX
    Cell Signal; 2008 Nov; 20(11):2002-12. PubMed ID: 18713649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.
    de Heer P; Koudijs MM; van de Velde CJ; Aalbers RI; Tollenaar RA; Putter H; Morreau J; van de Water B; Kuppen PJ
    Eur J Surg Oncol; 2008 Nov; 34(11):1253-61. PubMed ID: 18556171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.